Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues

Biological Chemistry

Volumn 387, Issue 6, 2006, Pages 783-788

  Planque, Chris ^a,b   Aïnciburu, Mireille ^a,b   Heuzé Vourc'h, Nathalie ^a,b   Régina, Sandra ^a,b   De Monte, Michèle ^c   Courty, Yves ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c IFR 135   (France)

Author keywords

Bronchus; Lung cancer; Real time PCR; Serine protease; Tissue kallikrein related protein

Indexed keywords

BIOLOGICAL MARKER; KALLIKREIN; KALLIKREIN 10; KALLIKREIN 11; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; CANCER SURVIVAL; COHORT ANALYSIS; CONFERENCE PAPER; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; LUNG; LUNG NEOPLASMS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS;

EID: 33745642942     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.098     Document Type: Conference Paper

References (31)

1. Bhattacharjee, A., Richards, W.G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13790-13795.
2. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
3. Borgono, C.A., Fracchioli, S., Yousef, G.M., Rigault de la Longrais, I.A., Luo, L.Y., Soosaipillai, A., Puopolo, M., Grass, L., Scorilas, A., Diamandis, E.P., and Katsaros, D. (2003). Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. Int. J. Cancer 106, 605-610.
4. Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2, 257-280.
5. Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265-312.
6. de Monte, M., Nonnenmacher, H., Brignon, N., Ullmann, M., and Martin, J.P. (2002). A multivariate statistical analysis to follow the course of disease after infection of cats with different strains of the feline immunodeficiency virus (FIV). J. Virol. Methods 103, 157-170.
7. Diamandis, E.P., Okui, A., Mitsui, S., Luo, L.Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D.J., and Yamaguchi, N. (2002). Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res. 62, 295-300.
8. Diamandis, E.P., Borgono, C.A., Scorilas, A., Harbeck, N., Dorn, J., and Schmitt, M. (2004). Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients. Clin. Biochem. 37, 823-829.
9. Garber, M.E., Troyanskaya, O.G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G.D., Perou, C.M., Whyte, R.I., et al. (2001). Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 98, 13784-13789.
10. Goyal, J., Smith, K.M., Cowan, J.M., Wazer, D.E., Lee, S.W., and Band, V. (1998). The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58, 4782-4786.
11. Houtmeyers, E., Gosselink, R., Gayan-Ramirez, G., and Decramer, M. (1999). Regulation of mucociliary clearance in health and disease. Eur. Respir. J. 13, 1177-1188.
12. Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1-14.
13. Liu, X.L., Wazer, D.E., Watanabe, K., and Band, V. (1996). Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56, 3371-3379.
14. Luo, L.Y., Bunting, P., Scorilas, A., and Diamandis, E.P. (2001a). Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin. Chim. Acta 306, 111-118.
15. Luo, L.Y., Grass, L., Howarth, D.J., Thibault, P., Ong, H., and Diamandis, E.P. (2001b). Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin. Chem. 47, 237-246.
16. Luo, L.Y., Rajpert-De Meyts, E.R., Jung, K., and Diamandis, E.P. (2001c). Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br. J. Cancer 85, 220-224.
17. Mitsui, S., Yamada, T., Okui, A., Kominami, K., Uemura, H., and Yamaguchi, N. (2000). A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate. Biochem. Biophys. Res. Commun. 272, 205-211.
18. Nakamura, T., Mitsui, S., Okui, A., Kominami, K., Nomoto, T., Ukimura, O., Kawauchi, A., Miki, T., and Yamaguchi, N. (2001). Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines. Prostate 49, 72-78.
19. Nakamura, T., Mitsui, S., Okui, A., Miki, T., and Yamaguchi, N. (2003a). Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate. Prostate 54, 299-305.
20. Nakamura, T., Stephan, C., Scorilas, A., Yousef, G.M., Jung, K,. and Diamandis, E.P. (2003b). Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology 61, 1042-1046.
21. Obiezu, C.V. and Diamandis, E.P. (2005). Human tissue kallikrein gene family: applications in cancer. Cancer Lett. 224, 1-22.
22. Pampalakis, G., Kurlender, L., Diamandis, E.P., and Sotiropoulou, G. (2004). Cloning and characterization of novel isoforms of the human kallikrein 6 gene. Biochem. Biophys. Res. Commun. 320, 54-61.
23. Petraki, C.D., Karavana, V.N., Luo, L.Y., and Diamandis, E.P. (2002). Human kallikrein 10 expression in normal tissues by immunohistochemistry. J. Histochem. Cytochem. 50, 1247-1261.
24. Petraki, C.D., Gregorakis, A.K., Papanastasiou, P.A., Karavana, V.N., Luo, L.Y., and Diamandis, E.P. (2003). Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues. Prostate Cancer Prostatic Dis. 6, 223-227.
25. Planque, C., de Monte, M., Guyetant, S., Rollin, J., Desmazes, C., Panel, V., Lemarie, E., and Courty, Y. (2005). KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Biochem. Biophys. Res. Commun. 329, 1260-1266.
26. Ramakers, C., Ruijter, J.M., Deprez, R.H., and Moorman, A.F. (2003). Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339, 62-66.
27. Shvartsman, H.S., Lu, K.H., Lee, J., Lillie, J., Deavers, M.T., Clifford, S., Wolf, J.K., Mills, G.B., Bast, R.C. Jr., Gershenson, D.M., and Schmandt, R. (2003). Overexpression of kallikrein 10 in epithelial ovarian carcinomas. Gynecol. Oncol. 90, 44-50.
28. Yoshida, S., Taniguchi, M., Suemoto, T., Oka, T., He, X., and Shiosaka, S. (1998). cDNA cloning and expression of a novel serine protease, TLSP. Biochim. Biophys. Acta 1399, 225-228.
29. Yousef, G.M., Borgono, C.A., White, N.M., Robb, J.D., Michael, I.P., Oikonomopoulou, K., Khan, S., and Diamandis, E.P. (2004a). In silico analysis of the human kallikrein gene 6. Tumour Biol. 25, 282-289.
30. Yousef, G.M., Yacoub, G.M., Polymeris, M.E., Popalis, C., Soosaipillai, A., and Diamandis, E.P. (2004b). Kallikrein gene downregulation in breast cancer. Br. J. Cancer 90, 167-172.
31. Zarghami, N., Levesque, M., D'Costa, M., Angelopoulou, K., and Diamandis, E.P. (1997). Frequency of expression of prostate-specific antigen mRNA in lung tumors. Am. J. Clin. Pathol. 108, 184-190.